bpc-157 fda news today FDA's Review Of Peptides Signals A Growing Public Health Challenge HIMS jumps more than 7%

HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer BREAKING: The peptide landscape just changed. The FDA advisory panel voted to recommend broader pharmacy compounding access for BPC 157, KPV, and TB 500. It's one of the biggest regulatory developments the peptide space FDA to discuss easing restrictions on peptides despite safety concerns US healthcare The Guardian FDA panel votes to place popular peptide BPC 157 on compounding list Reuters

SKU: 87432014923 · From l2q2.es